Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03149822
Title Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

renal cell carcinoma

Therapies

Cabozantinib + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.